로딩 중…
StockDiggingStockDigging

Integra LifeSciences Holdings Corporation

IART· NASDAQ
$13.62+6.82%
2026-11-02

Financials

Valuation Metrics

Integra LifeSciences Holdings Corporation's Market Cap is $1.06B. At end of 2025 it was $953M. Ranked #2412 of 3,118 in US market (top 77%), #981 of 1,474 on NASDAQ (top 67%), #154 of 203 in Health Care Equipment & Services (top 76%) by Market Cap.

Investment Metrics(as of 2026-11-02)

MetricValue
Size
Market Cap$1.06B
Revenue$1.66B
Net Income$13M
Total Assets$3.51B
Net Assets$1.07B
Employees4,427
Value
P/E81.43x
P/B0.99x
P/S0.64x
EV/EBITDA12.02x
FCF Yield9.32%
Profitability
ROE1.22%
ROA0.37%
Op. Margin38.30%
Revenue Growth0.84%
Financial Health
Debt Ratio228.87%
Total Debt$2.00B
FCF$99M
Cash$252M
Current Ratio3.62x
Net Debt/EBITDA7.49x
Dividend
Div. Yield0.00%
Payout Ratio0.00%
Performance
1Y Return13.41%
1M Return7.41%
From 52W High-33.53%
1Y MDD-44.79%
Trading
Volume1,279,718 shares
Trading Value$17M
Per Share
EPS$0.17
BPS$13.71

Company Info

CEO Ms. Mojdeh Poul
Employees 4,427
HQ Princeton, United States

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.